Through the continued release of pro-inflammatory cytokines and upregulation of growth factors, including TGF-ß, vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF), myofibroblasts transform into carcinoma-associated fibroblasts (CAFs) [18,19]. Here, VEGFA is linked to carcinoma.